Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia

This study has been completed.

Sponsor:

Collaborators:

Associazione Italiana Ematologia Oncologia Pediatrica

BFM-A, Austria

BFM-G, Germany and Switzerland

CPH, Czech republic

European Organisation for Research and Treatment of Cancer - EORTC

GATLA, Argentina

H-POG, Hungary

PINDA, Chile

Information provided by:

International BFM Study Group

ClinicalTrials.gov Identifier:

NCT00411541

First received: December 13, 2006

Last updated: NA

Last verified: December 2006

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2004
Estimated Primary Completion Date:	No date given

No publications provided by International BFM Study Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Conter V, Valsecchi MG, Silvestri D, Campbell M, Dibar E, Magyarosy E, Gadner H, Stary J, Benoit Y, Zimmermann M, Reiter A, Riehm H, Masera G, Schrappe M. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. Lancet. 2007 Jan 13;369(9556):123-31.

To Top